Denosumab Injection By Hepra Pharmaceutical

8800 INR (Approx.)

136 INR (Approx.)

124225 INR (Approx.)

Liquid

Injection

Liquid

Liquid

sterile, lyophilized powder

Take Exactly as Directed by A Doctor or As Mentioned on The Label; Dosage May Vary Based on Age, Weight, and Medical Condition

As Per Physician

Dosage Guidelines Administration: Subcutaneous injection (not IV or IM). Starting dose (adults): -thalassemia: 1 mg/kg once every 3 weeks. Myelodysplastic syndromes (MDS): 1 mg/kg once every 3 weeks. Adjustment: If response is inadequate, dose may be increased to 1.25 mg/kg (maximum). Dose interruptions or reductions may be required for side effects (e.g., high hemoglobin, hypertension, bone pain). Treatment goal: Reduce or eliminate the need for red blood cell transfusions. Reconstitution: Each vial must be reconstituted with sterile water before injection

Dry Place, Keep out Of Reach of Children

Cool & Dry Places

Store in Cool

10 Per Week

100 Per Day

100 Per Day

As per the Industrial Standard

Packaging DetailsForm: Lyophilized powder for solution (white to off-white).Strengths available:25 mg/vial75 mg/vialContainer: Type I clear glass vial with a rubber stopper and flip-off aluminum seal.Presentation: Each carton contains 1 single-dose vial.Labeling: Vial label and outer carton show drug name (Reblozyl / Luspatercept-aamt), strength, batch/lot number, expiry date, and storage conditions.Reconstitution: Supplied without diluent; requires Sterile Water for Injection (provided separately by healthcare facility).Storage: Refrigerated at 2 C to 8 C, protected from light.

Yes

No